VANGUARD GROUP INC - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 34 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$4,068,000
+2.6%
221,371
+2.4%
0.00%
Q3 2020$3,966,000
+21.9%
216,256
-0.5%
0.00%
Q2 2020$3,253,000
-2.4%
217,294
+3.2%
0.00%
Q1 2020$3,332,000
-2.5%
210,609
+0.1%
0.00%
Q4 2019$3,417,000
+8.2%
210,375
-1.0%
0.00%
Q3 2019$3,157,000
-9.6%
212,417
+0.6%
0.00%
Q2 2019$3,491,000
-6.0%
211,172
-1.6%
0.00%
Q1 2019$3,713,000
+8.7%
214,633
+10.9%
0.00%
Q4 2018$3,417,000
+2.4%
193,481
+5.3%
0.00%
Q3 2018$3,337,000
-3.2%
183,828
+4.2%
0.00%
Q2 2018$3,448,000
+38.3%
176,385
+24.2%
0.00%
Q1 2018$2,493,000
+164.4%
142,033
+71.0%
0.00%
Q4 2017$943,000
+6.6%
83,0710.0%0.00%
Q3 2017$885,000
+13.0%
83,071
-7.2%
0.00%
Q2 2017$783,000
-44.5%
89,551
-25.1%
0.00%
Q1 2017$1,412,000
-9.7%
119,610
+0.2%
0.00%
Q4 2016$1,564,000
-1.1%
119,382
+9.5%
0.00%
Q3 2016$1,581,000
+27.5%
109,023
+5.4%
0.00%
Q2 2016$1,240,000
-34.7%
103,415
+1.5%
0.00%
Q1 2016$1,900,000
+20.6%
101,874
+38.9%
0.00%
Q4 2015$1,576,000
-99.1%
73,354
-98.4%
0.00%
-100.0%
Q3 2015$168,033,000
+12201.1%
4,618,390
+12575.7%
0.01%
Q2 2015$1,366,000
+404.1%
36,435
+323.1%
0.00%
Q1 2015$271,0008,6110.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q4 2015
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 52,468$964,0001.05%
Olympiad Research LP 54,795$1,007,0000.58%
Alpine Global Management, LLC 119,902$2,204,0000.45%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,922$1,212,0000.19%
First Trust Capital Management L.P. 32,688$601,0000.17%
GLAZER CAPITAL, LLC 232,103$4,266,0000.15%
Walleye Capital LLC 105,000$1,930,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.08%
Dynamic Technology Lab Private Ltd 17,929$330,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$195,0000.05%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders